Petaling Jaya, Malaysia, August 30, 2024 – DKSH Business Unit Healthcare, a leading strategic partner for companies seeking to grow their healthcare business in Asia and beyond, has successfully entered into a strategic partnership with Alpro Pharmacy, the largest prescription pharmacy chain in Malaysia. This collaboration aims to increase access, through addressing affordability challenges, to essential medication for all patients nationwide. Moreover, this partnership enhances the well-being of Thalassemia patients, strengthens Malaysia’s healthcare landscape, and aligns seamlessly with Alpro Pharmacy’s vision and initiative of ONCOHelp – a one-stop center for cancer patients across Malaysia.
Under the agreement, DKSH’s Patient Access Program (PAP) will provide financial support to patients from selected Alpro Pharmacies.
DKSH’s Patient Solutions support network is expanding across eight markets in APAC; touching the lives of many patients, healthcare professionals, and healthcare brands through various patient support programs that address challenges patients face in their treatment journey from accessibility to education and convenience. The team actively listens to the needs of its stakeholders and strives to continuously address them, tackling challenges in healthcare delivery and consumption across APAC. This partnership with Alpro Pharmacy will increase accessibility of drugs for patients and lead to adherence and hence improved treatment outcomes.
Joelle Wong Pei Sen, Chief Pharmaceutical Officer, ONCOHelp, Alpro Pharmacy, commented: “DKSH’s regional experience in managing Patient Access Programs across the Asia Pacific region (APAC) is essential for benefiting our patients. Together, we are confident that we can enhance healthcare accessibility and improve the quality of life for many individuals across Malaysia.”
Sandeep Tewari, Head Country Management and Vice President, Healthcare, DKSH Malaysia, added: “DKSH’s mission is to enrich people’s quality of life by providing better healthcare solutions. Our goal is to address the challenges patients encounter throughout their treatment journey. The PAP aims to make high-cost drugs more accessible. Through this collaboration, patients can conveniently obtain medications from designated Alpro Pharmacy outlets near their treating hospitals ensuring healthcare for all. This partnership also supports the well-being of Thalassemia patients and positively impacts the overall Malaysia’s healthcare landscape.”
